KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.
about
Melanoma: from melanocyte to genetic alterations and clinical optionsPathogenesis, diagnosis and management of primary melanoma of the colon.Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.Primary malignant melanoma of the transverse colon: report of a case and review of the literature.Amelanotic malignant melanoma of the esophagus: report of two cases with immunohistochemical and molecular genetic study of KIT and PDGFRA.Immunohistochemical analysis of molecular drivers in melanoma identifies p16 as an independent prognostic biomarker.
P2860
KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
KIT receptor is expressed in m ...... pective study of 261 patients.
@en
KIT receptor is expressed in m ...... pective study of 261 patients.
@nl
type
label
KIT receptor is expressed in m ...... pective study of 261 patients.
@en
KIT receptor is expressed in m ...... pective study of 261 patients.
@nl
prefLabel
KIT receptor is expressed in m ...... pective study of 261 patients.
@en
KIT receptor is expressed in m ...... pective study of 261 patients.
@nl
P2093
P50
P1433
P1476
KIT receptor is expressed in m ...... pective study of 261 patients.
@en
P2093
Gabriela Kocmanova
Ivan Julis
Ivana Julisova
Ivana Krajsova
Jan Novotny
Ladislav Pecen
Luboslava Krasna
P304
P356
10.1097/00008390-200508000-00004
P407
P577
2005-08-01T00:00:00Z